Bumper Offer - Urjas oil Just @ Rs. 1
Tellzy RS 40 Tablet (15), a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Heart Failure, High BP. The alternative uses of Tellzy RS 40 Tablet (15) have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Tellzy RS 40 Tablet (15). The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Tellzy RS 40 Tablet (15) include Dizziness, Nausea or vomiting, Back Pain. Besides the aforementioned side effects, there are other adverse effects of Tellzy RS 40 Tablet (15) as well, which are listed below. Normally, these side effects of Tellzy RS 40 Tablet (15) are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Tellzy RS 40 Tablet (15) has a Severe effect for pregnant women and Mild effect on lactating mothers. Warnings related to Tellzy RS 40 Tablet (15)'s effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Angioedema, Hyperkalemia, Drug Allergy must refrain from the use of Tellzy RS 40 Tablet (15) since this can cause severe adverse effects.
Besides this, Tellzy RS 40 Tablet (15) may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Tellzy RS 40 Tablet (15) is not safe while driving, and is is not addictive in nature.
Tellzy RS 40 Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Tellzy RS 40 Tablet (15) is used -
Severe
Mild
Common
Is the use of Tellzy RS 40 Tablet (15) safe for pregnant women?
Tellzy should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Tellzy RS 40 Tablet (15) safe during breastfeeding?
Tellzy may have very limited harmful effects for breastfeeding women.
What is the effect of Tellzy RS 40 Tablet (15) on the Kidneys?
Tellzy is not harmful for kidneys.
What is the effect of Tellzy RS 40 Tablet (15) on the Liver?
Tellzy may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Tellzy RS 40 Tablet (15) on the Heart?
Tellzy has very mild side effects on the heart.
Tellzy RS 40 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Tellzy RS 40 Tablet (15) unless your doctor advises you to do so -
Is this Tellzy RS 40 Tablet (15) habit forming or addictive?
Tellzy RS 40 Tablet (15) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Tellzy RS 40 Tablet (15) can make you feel drowsy.
Is it safe?
Tellzy RS 40 Tablet (15) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Tellzy RS 40 Tablet (15) cannot treat any kind of mental disorder.
Interaction between Food and Tellzy RS 40 Tablet (15)
Tellzy RS 40 Tablet (15) may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Tellzy RS 40 Tablet (15)
Consuming Tellzy RS 40 Tablet (15) with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
